Provided by Tiger Fintech (Singapore) Pte. Ltd.

Monopar Therapeutics

32.62
+3.7012.79%
Post-market: 32.620.00000.00%19:13 EDT
Volume:20.01K
Turnover:608.85K
Market Cap:199.39M
PE:-7.93
High:33.38
Open:29.61
Low:26.06
Close:28.92
Loading ...
Nov 04, 2019

[Amend]Public Prospectus

[Amend] General form for registration of securities under the Securities Act of 1933
Nov 04, 2019

[Amend]Public Prospectus

[Amend] General form for registration of securities under the Securities Act of 1933
Oct 02, 2019

Correspondence

[Cover]Correspondence
Oct 02, 2019

Correspondence

[Cover]Correspondence
Oct 01, 2019

[Amend]Public Prospectus

[Amend] General form for registration of securities under the Securities Act of 1933
Sep 30, 2019

Correspondence

[Cover]Correspondence
Sep 23, 2019

[Supp]Public Prospectus

Filing under Securities Act Rules 163/433 of free writing prospectuses
Sep 13, 2019

[Amend]Public Prospectus

[Amend] General form for registration of securities under the Securities Act of 1933
Sep 10, 2019

[Amend]Public Prospectus

[Amend] General form for registration of securities under the Securities Act of 1933
Aug 15, 2019

Public Prospectus

General form for registration of securities under the Securities Act of 1933
Aug 08, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Jun 27, 2019

Major Issues Report

Current report, item 5.07
May 10, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Feb 26, 2019

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Dec 11, 2018

Correspondence

[Cover]Correspondence
Dec 11, 2018

[Rev.]Annual Report

[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]
Dec 11, 2018

[Rev.]Quaterly Report

[Amend] Quarterly report [Sections 13 or 15(d)]
Dec 11, 2018

[Rev.]Quaterly Report

[Amend] Quarterly report [Sections 13 or 15(d)]
Dec 11, 2018

[Rev.]Quaterly Report

[Amend] Quarterly report [Sections 13 or 15(d)]
Nov 09, 2018

Quarterly Report

Quarterly report [Sections 13 or 15(d)]